Correlation Between Catalyst Pharmaceuticals and Valens
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Valens at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Valens into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and Valens, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Valens and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Valens. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Valens.
Diversification Opportunities for Catalyst Pharmaceuticals and Valens
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Catalyst and Valens is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Valens in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Valens and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Valens. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Valens has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Valens go up and down completely randomly.
Pair Corralation between Catalyst Pharmaceuticals and Valens
Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 0.49 times more return on investment than Valens. However, Catalyst Pharmaceuticals is 2.04 times less risky than Valens. It trades about -0.06 of its potential returns per unit of risk. Valens is currently generating about -0.08 per unit of risk. If you would invest 2,186 in Catalyst Pharmaceuticals on August 28, 2024 and sell it today you would lose (67.00) from holding Catalyst Pharmaceuticals or give up 3.06% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Catalyst Pharmaceuticals vs. Valens
Performance |
| Timeline |
| Catalyst Pharmaceuticals |
| Valens |
Catalyst Pharmaceuticals and Valens Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Catalyst Pharmaceuticals and Valens
The main advantage of trading using opposite Catalyst Pharmaceuticals and Valens positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Valens can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valens will offset losses from the drop in Valens' long position.| Catalyst Pharmaceuticals vs. Eliem Therapeutics | Catalyst Pharmaceuticals vs. HCW Biologics | Catalyst Pharmaceuticals vs. Scpharmaceuticals | Catalyst Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |